Coexistence of mental and somatic diseases and difficulties in diagnosis and working with mentally ill people
DOI:
https://doi.org/10.12775/JEHS.2022.12.07.065Keywords
mental disorders, depression, schizophrenia, feeding and eating disorders, anxiety disordersAbstract
Abstract
Introduction and purpose:
The co-occurrence of mental illness and somatic diseases is a relationship confirmed by researchers in the fields of clinical medicine, health psychology or neuroscience. This article aims to present and discuss the interrelationship between mental and somatic diseases and to present issues related to the process of diagnosis.
State of knowledge (brief description):
Depression, schizophrenia, eating disorders and anxiety disorders are mental illnesses cited among researchers on the basis of studies as particularly prone to somatic comorbidities. Among somatic diseases, on the other hand, cancer is cited as the most frequently implicated in psychiatric comorbidity. However, this is not a clear-cut problem, as the impact of somatic and mental illnesses on each other can be bidirectional. Diagnosis of these requires a physician to have a great deal of factual knowledge and great vigilance in conducting an interview that may be conducted not only with the patient, but also with his family or environment.
Summary:
Working with people who are both mentally and somatically ill is a job that requires knowledge that combines both disciplines. Data indicate that 20-35% of patients with chronic somatic disease also have an additional psychiatric diagnosis; somatization of mental problems is a common phenomenon in outpatient treatment.
References
DSM - V American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.), 2013
Otlewska A. Współistnienie chorób somatycznych i psychicznych. Medycyna Ogólna i Nauki o Zdrowiu. 2018;24(1):54-58
Jabłońska E, Błądkowska K, Bronkowska M. Zaburzenia odżywiania jako problem zdrowotny i psychospołeczny. Kosmos. 2019;68(1):121-132
Pavlekovic G, Donev D, Kragelj LZ. Health Promotion Glossary: Selected Terms and Comments. Programmes for Training on Research in Public Health for South Eastern Europe. 2008:789-803
McGuire J. Genetic Factors Behind Eating Disorders. Eating Disorder Hope [Internet]. 2017 https://www.eatingdisorderhope.com/blog/genetic-factors-eating-disorders
Are People Genetically Predisposed for Eating Disorders? [Internet]. Eating Disorder Hope. [cytowane 11 lipiec 2020]. Dostępne na: https://www.eatingdisorderhope.com/information/eating-disorder/people-genetically-predisposed-eds
Trace SE, Baker JH, Peñas-Lledó E, Bulik CM. The genetics of eating disorders. Annu Rev Clin Psychol. 2013;9:589-620
Berrettini W. The genetics of eating disorders. Psychiatry (Edgmont). 2004 Nov;1(3):18-25
Fichter MM, Quadflieg N. Mortality in eating disorders - results of a large prospective clinical longitudinal study. Int J Eat Disord. 2016 Apr;49(4):391-401
Gosseaume C, Dicembre M, Bemer P, Melchior J-C, Hanachi M. Somatic complications and nutritional management of anorexia nervosa. Clinical nutrition experimental. 2019;28:2-10.
de Simone G, Scalfi L, Galderisi M, Celentano A, Di Biase G, Tammaro P, Garofalo M, Mureddu GF, de Divitiis O, Contaldo F. Cardiac abnormalities in young women with anorexia nervosa. Br Heart J. 1994 Mar;71(3):287-92
Romano C, Chinali M, Pasanisi F, Greco R, Celentano A, Rocco A, Palmieri V, Signorini A, Contaldo F, de Simone G. Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosa. Am J Clin Nutr. 2003 Feb;77(2):308-12
International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021
Kiejna A, Piotrowski P, Adamowski T, Moskalewicz J, Wciórka J, Stokwiszewski J, et al. Rozpowszechnienie wybranych zaburzeń psychicznych w populacji dorosłych Polaków z odniesieniem do płci i struktury wieku-badanie EZOP Polska. Psychiatria Polska. 2015:15-27.
Tylee A, Gandhi P. The importance of somatic symptoms in depression in
primary care. Prim Care Companion J Clin Psychiatry. 2005;7:167-176.
Kapfhammer HP. Somatic symptoms in depression. Dialogues Clin Neurosci. 2006;8(2):227-39
Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry. 1989 Feb;154:201-6.
Wasilewski D, Wojnar M, Chatizow J. Depresja a ból: ogólnopolskie badanie epidemiologiczne. Psychiatr Pol. 2010;44(3):435-45.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Archives of internal medicine. 2003;163(20):2433-45.
Gameroff MJ, Olfson M. Major depressive disorder, somatic pain, and health care costs in an urban primary care practice. J Clin Psychiatry. 2006 Aug;67(8):1232-1239
Robinson MJ, Edwards SE, Iyengar S, Bymaster F, Clark M, Katon W. Depression and pain. Front Biosci (Landmark Ed). 2009 Jun 1;14(13):5031-51.
Roth, M. L., Tripp, D. A., Harrison, M. H., Sullivan, M., & Carson, P. (2007). Demographic and psychosocial predictors of acute perioperative pain for total knee arthroplasty. Pain research & management, 12(3), 185–194.
Piotrowicz R, Potocka J, Araszkiewicz A. Depresja jako problem kardiologiczny w praktyce lekarzy podstawowej opieki zdrowotnej. Folia Cardiologica. 2003;10(2):177-84.
Sartorius, N., Ustün, T. B., Costa e Silva, J. A., Goldberg, D., Lecrubier, Y., Ormel, J., Von Korff, M., & Wittchen, H. U. (1993). An international study of psychological problems in primary care. Preliminary report from the World Health Organization Collaborative Project on 'Psychological Problems in General Health Care'. Archives of general psychiatry, 50(10), 819–824.
Sartorius N, Ustün TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl. 1996 Jun;(30):38-43.
ENRICHD Investigators. Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics. Am J Cardiol. 2001 Aug 1;88(3):316-22.
Wróblewski H, Chojęta D, Zimna A, Zygmunt E, Kozłowska A, Mierzwa M, et al. Psychiatric manifestations of rheumatic diseases. Journal of Education, Health and Sport. 2022;12(8):52-60.
Meszaros ZS, Perl A, Faraone SV. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry. 2012 Jul;73(7):993-1001
Fanouriakis A, Bertsias G, Govoni M. Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus. Front Med (Lausanne). 2019 Mar 26;6:52
Hsieh MC, Hsu CW, Lu MC, Koo M. Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data. Clin Rheumatol. 2019 Nov;38(11):3195-3203.
McNair S, Hategan A, Bourgeois JA, Losier B. Neuropsychiatric Symptoms in Scleroderma. Psychosomatics. 2013;54(4):382-386.
Mura G, Bhat KM, Pisano A, Licci G, Carta M. Psychiatric symptoms and quality of life in systemic sclerosis. Clin Pract Epidemiol Ment Health. 2012;8:30-5.
Mozzetta A, Antinone V, Alfani S, Neri P, Foglio Bonda PG, Pasquini P, Puddu P, Picardi A. Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol. 2008 Mar;22(3):336-40.
Kieszkowska-Grudny A. Zaburzenia psychiczne u chorych na nowotwory – podejście kliniczne. Onco Review 2013; 3(2):119–128
Lopez AD, Murray CCJL. The global burden of disease, 1990–2020. Nature Medicine. 1998;4(11):1241-3
McGrath J, Saha S, Chant D, Welham J. Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality. Epidemiologic Reviews. 2008;30(1):67-76..
Gaebel W. Status of Psychotic Disorders in ICD-11. Schizophrenia Bulletin. 2012;38(5):895-8.
McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia—An Overview. JAMA Psychiatry. 2020;77(2):201-10.
Rybakowski J. Etiopatogeneza schizofrenii–stan wiedzy na rok 2021. Psychiatr Pol. 2021;55(2):261-74.
Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. The British journal of psychiatry. 2000;177(3):212-217.
Mitchell AJ, Malone D: Physical health and schizophrenia. Curr Opin Psychiatry 2006, 19(4):432-437.
Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust. 2003 May 5;178(S9):S67-70.
Balf G, Stewart TD, Whitehead R, Baker RA. Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective. Prim Care Companion J Clin Psychiatry. 2008;10(1):15-24.
Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007 Nov;116(5):317-33.
Ward M, Druss B. The epidemiology of diabetes in psychotic disorders. Lancet Psychiatry. 2015 May;2(5):431-451.
Klimek P, Kautzky-Willer A, Chmiel A, Schiller-Frühwirth I, Thurner S. Quantification of diabetes comorbidity risks across life using nation-wide big claims data. PLoS Comput Biol. 2015 Apr 9;11(4):e1004125.
Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011 Dec;168(12):1303-10.
Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, Maj M, McIntyre RS, Naber D, Newcomer JW, Olfson M, Osby U, Sartorius N, Lieberman JA. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry. 2008 Apr;69(4):514-9.
Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. American Heart Journal. 2005;150(6):1115-21.
Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry. 1998 Jul;173:11-53
Dudek D. Zespół metaboliczny u pacjentów ze schizofrenią. Forum Zaburzeń Metabolicznych. 2010;1(3):123-30.
Kiejna A, Piotrowski P, Adamowski T. Schizofrenia. Perspektywa społeczna. Sytuacja w Polsce. Wrocław: Fundacja Ochrony Zdrowia Psychicznego; 2013. (Unreviewed article, only definition used)
Ventriglio A, Gentile A, Stella E, Bellomo A. Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management. Front Neurosci. 2015 Sep 3;9:297.
Luks M, Rzewuska M, Ziółkowska A, Kuczyński W. Przyrost masy ciała związany z lekami antypsychotycznymi. Farmakoterapia w Psychiatrii i Neurologii. 2001;1:113-5.
Klejna A, Piotrowski P, Adamowski T. Rozpowszechnienie wybranych zaburzeń psychicznych w populacji dorosłych aków z odniesieniem do płci i struktury wieku-Badanie EZOP ska. Psychiatr Pol. 2015;49(1):15-27.
Skulimowska K. Wzajemne wpływy stan u somatycznego i psychicznego u pacjentów z rozpoznaniem choroby somatycznej i z zaburzeniem nerwicowym. Psychoterapia 2011; 3(158):41–59.
Brzoza Z, Badura-Brzoza K, Nowakowski M. Objawy lęku i depresji w przebiegu atopowego wyprysku/zapalenia skóry. Psychiatr. Pol. 2005; 39(4): 691–699
Pawłowski T, Baranowski P, Małyszczak K, Frydecka D, Chlebowska I. Zaburzenie lękowe z napadami lęku. Adv Clin Exp Med 2006; 15(1):163–170.
Kantorovich V, Eisenhofer G, Pacak K. Pheochromocytoma: an endocrine stress mimicking disorder. Ann N Y Acad Sci. 2008 Dec;1148:462-8.
Zardawi IM. Phaeochromocytoma masquerading as anxiety and depression. Am J Case Rep. 2013 May 20;14:161-163.
Nitka-Siemińska A. Zaburzenia lękowe – charakterystyka i zasady leczenia. Forum Medycyny Rodzinnej 2014; 8(1):37–43.
Bandelow B, Werner AM, Kopp I, Rudolf S, Wiltink J, Beutel ME. The German Guidelines for the treatment of anxiety disorders: first revision. Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):571-582.
Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H, Pedersen BK. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 2007 Feb;50(2):431-8
Roose SP, Glassman AH, Seidman SN. Relationship between depression and other medical illnesses. JAMA. 2001 Oct 10;286(14):1687-90.
Skulimowska K, Siwak-Kobayashi M, Galińska E. Problemy psychoterapii pacjentów z przewlekłą chorobą zagrażającą życiu leczonych w Klinice Nerwic. Post. Psych. i Neurol. 2000; 9, supl. 3(11):121–128.
Siwiak-Kobayashi M. Komentarz do artykułu. Mitchell D. Feldman: Leczenie zaburzeń psychicznych w warunkach podstawowej opieki zdrowotnej. Lęk. Med. Dypl; 2001; 10(2):183–193
Dudek D, Siwek M. Współistnienie chorób somatycznych i depresji. Psychiatria. 2007;4(1):17-24.
Wright CA, Osborn DP, Nazareth I, King MB. Prevention of coronary heart disease in people with severe mental illnesses: a qualitative study of patient and professionals' preferences for care. BMC Psychiatry. 2006 Apr 21;6:16.
Oud MJ, Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract. 2009 May 9;10:32.
Oud MJ, Schuling J, Slooff CJ, Meyboom-de Jong B. How do General Practitioners experience providing care for their psychotic patients? BMC Fam Pract. 2007 Jun 28;8:37.
Haussleiter I, Emons B, Hoffmann K, Juckel G. The somatic care situation of people with mental illness. Health Science Reports. 2021;4(1):e226.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Piotr Janeczek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 350
Number of citations: 0